MedTrace Logo

Gen2 Isthmus-Dependent Atrial Flutter Ablation Study

NCT00606463 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-07-14

No results posted yet for this study

Summary

Irrigated catheter for ablation of isthmus-dependent atrial flutter

Conditions

  • Atrial Flutter

Interventions

DEVICE

Cardiac Ablation (Gen2 Cardiac Ablation System)

Ablation of isthmus-dependent atrial flutter

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Vance Plumb, MD · University of Alabama at Birmingham

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-08-31
Completion
2009-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00606463 on ClinicalTrials.gov